AR-2302 Small Molecule Collaboration

Diabetes/Obesity

Current Stage: Pre-clinical

Hit Discovery

Lead Optimization

Preclinical

Clinical

Indication (EN)

Diabetes/Obesity

Indication (KO)

당뇨/비만

Modality

Small Molecule

Program Type

Collaboration

Interested in Collaboration?

If this program aligns with your therapeutic area, we would be glad to explore partnership opportunities.

Contact Us bd@arontier.co

Back to Pipeline